Naloxone Accord (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Accord, is an opioid antagonist presented as a sterile solution for intramuscular and intravenous use. It reverses opioid overdose and opioid‑induced respiratory depression in emergency situations.

GNH USA supplies Naloxone Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone is an opioid antagonist used in emergency medicine to counteract opioid toxicity. - Opioid overdose: rapidly restores normal respiration and consciousness. - Opioid‑induced respiratory depression: reverses breathing suppression caused by opioid analgesics. - Acute opioid toxicity: counteracts sedation and pinpoint pupils, stabilizing vital signs.

Naloxone may cause a range of adverse reactions, most of which are related to abrupt opioid withdrawal or injection site irritation.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis following administration. - Sweating: increased perspiration. - Headache: transient cranial discomfort. - Dizziness: light‑headed sensation. - Injection site pain: local discomfort at the site of administration.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Cardiac arrest: rare but life‑threatening event. - Pulmonary edema: fluid accumulation in lungs. - Seizures: occasional convulsive episodes. - Anaphylaxis: severe allergic reaction. - Arrhythmias: abnormal heart rhythms.

Naloxone should be used with careful clinical assessment and monitoring. - Assess airway and breathing: ensure patient can maintain adequate ventilation before and after administration. - Monitor for withdrawal: observe for agitation, anxiety, or tachycardia in opioid‑dependent individuals. - Use in controlled setting: administer where resuscitation equipment is available. - Caution in cardiovascular disease: watch for rapid blood pressure changes. - Store below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Naloxone may interact with other medications that affect the central nervous system or opioid pathways.

Major Interactions (Avoid): - Concurrent potent opioid agonists: may precipitate severe withdrawal. - Mixed agonist‑antagonist opioids (e.g., buprenorphine): reduced efficacy of naloxone. - Drugs that lower seizure threshold: increased risk of seizures.

Moderate Interactions (Monitor Closely): - Monoamine oxidase inhibitors (MAOIs): potential for hypertensive reactions. - Tricyclic antidepressants: may enhance cardiovascular effects. - Central nervous system depressants: monitor respiratory status closely.